Liquid saliva-based Raman spectroscopy device with on-board machine learning detects COVID-19 infection in real-time.

Journal: The Analyst
Published Date:

Abstract

With greater population density, the likelihood of viral outbreaks achieving pandemic status is increasing. However, current viral screening techniques use specific reagents, and as viruses mutate, test accuracy decreases. Here, we present the first real-time, reagent-free, portable analysis platform for viral detection in liquid saliva, using COVID-19 as a proof-of-concept. We show that vibrational molecular spectroscopy and machine learning (ML) detect biomolecular changes consistent with the presence of viral infection. Saliva samples were collected from 470 individuals, including 65 that were infected with COVID-19 (28 from hospitalized patients and 37 from a walk-in testing clinic) and 251 that had a negative polymerase chain reaction (PCR) test. A further 154 were collected from healthy volunteers. Saliva measurements were achieved in 6 minutes or less and led to machine learning models predicting COVID-19 infection with sensitivity and specificity reaching 90%, depending on volunteer symptoms and disease severity. Machine learning models were based on linear support vector machines (SVM). This platform could be deployed to manage future pandemics using the same hardware but using a tunable machine learning model that could be rapidly updated as new viral strains emerge.

Authors

  • Katherine J I Ember
    Department of Engineering Physics, Polytechnique Montréal, Montreal, Quebec, Canada. frederic.leblond@polymtl.ca.
  • Nassim Ksantini
    Department of Engineering Physics, Polytechnique Montréal, Montreal, Quebec, Canada. frederic.leblond@polymtl.ca.
  • Frédérick Dallaire
    Centre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
  • Guillaume Sheehy
    Department of Engineering Physics, Polytechnique Montréal, Montreal, Quebec, Canada. frederic.leblond@polymtl.ca.
  • Trang Tran
    Department of Engineering Physics, Polytechnique Montréal, Montreal, Quebec, Canada. frederic.leblond@polymtl.ca.
  • Mathieu Dehaes
    Department of Radiology, Radio-oncology and Nuclear Medicine, Université de Montréal, Montreal, Canada.
  • Madeleine Durand
    Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
  • Dominique Trudel
    Centre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
  • Frederic Leblond
    Polytechnique Montreal, Department of Engineering Physics, CP 6079, Succ. Centre-Ville, Montreal, Quebec H3C 3A7, CanadadCentre de Recherche du Centre Hospitalier de l'Université de Montréal, 900 rue Saint-Denis, H2X 0A9 Quebec, Canada.